The overview discusses fifty eight peptides in numerous clinical phases, indicating a sturdy pipeline of peptide therapies concentrating on PPIs. These approaches open new avenues for treatments personalized to battle unique breast cancer subtypes and glioblastoma by honing in on integrins, fibronectins, and matrix metalloproteinases. To assist support the investigation, https://ericr714hgd5.wikijournalist.com/user